Renwei G. Luo
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study.
Journal: Psoriasis (Auckland, N.Z.)
Published: March 31, 2025
Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations.
Journal: American journal of clinical dermatology
Published: January 13, 2025
The L-shaped association between weight-adjusted-waist index and all-cause mortality in individuals with psoriasis: results from NHANES database retrospective cohort study.
Journal: Frontiers in immunology
Published: December 20, 2024
Proteomic Profiling and Clinical Insights: The Role of MMP9 in Differentiating Psoriasis Vulgaris from Generalized Pustular Psoriasis.
Journal: Journal of inflammation research
Published: September 24, 2024
Comparative Efficacy and Safety of Ustekinumab and Secukinumab in the Treatment of Generalized Pustular Psoriasis: A 48-Week Retrospective Cohort Study with Genetic Background Analysis.
Journal: Journal of inflammation research
Published: April 05, 2024
Application and Comparison of Dermoscopy and Reflectance Confocal Microscopy in the Target Treatment of Genital Lichen Sclerosus: A Single-Arm Prospective Study.
Journal: Dermatology and therapy
Published: July 07, 2023
Efficacy and tolerability of oral upadacitinib monotherapy in patients with recalcitrant vitiligo.
Journal: Journal of the American Academy of Dermatology
Published: July 04, 2023
The efficacy and safety analysis of cervical and abdominal double single-port minimally invasive esophagectomy
Journal: Zhonghua yi xue za zhi
Published: June 12, 2023
APOA4 as a novel predictor of prognosis in Stevens-Johnson syndrome/toxic epidermal necrolysis: A proteomics analysis from two prospective cohorts.
Journal: Journal of the American Academy of Dermatology
Published: January 05, 2023
Abrocitinib as a novel treatment for lichen sclerosus.
Journal: The British journal of dermatology
Published: December 30, 2022
Case Report: Successful Treatment of Kaposi's Sarcoma With Anlotinib in an HIV-Negative Patient After the Treatment of Drug Reaction With Eosinophilia and Systemic Symptoms Accessory Tragus.
Journal: Frontiers in medicine
Published: March 29, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026